We evaluated the effect of memantine on visual hallucination, cognitive abilities and so on from baseline to 4 months after the start of medication.
Treatment of the patient with memantine resulted in the disappearance of visual hallucinations but could not stop the progression to dementia.
Our results suggested that, for a patient having preclinical DLB, memantine had some degree of positive effects, but the mechanism remains to be revealed.